MRNS $14.7 -2.39% (-0.36) unusual options activity for all expirations

Filter By Expiration: Weekly - Monthly - Long Term - All

Traded Dollars Split By Sentiment & Expiry

Bullish Marinus Pharmaceuticals, Inc. call option contracts are ones that are bought on or above the market's asking price OR put option contracts that are sold on or less than the market's bid price - expecting a move to the upside.
The opposite applies to bearish trades: put options bought on or above the ask OR call options sold at or below the bid price - expecting a move to the downside.



Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of neuropsychiatric therapeutics. Its clinical stage drug candidate, ganaxolone, is a novel synthetic small molecule that is an analog of allopregnanolone, a natural occurring neurosteriod produced by the human body, which modulates gamma-aminobutyric acid a neurotransmitter in the brain. The company was founded by Geoffrey E. Chaiken, Harry H. Penner Jr., Vincent A. Pieribone and Kenneth R. Shaw on August 14, 2003 and is headquartered in Radnor, PA.

Weighted Average Of Option Greeks


How To Trade MRNS Unusual Options Activity There are many ways to interpret UOA. Some common strategies include looking at the strike prices and comparing them to the current stock price for Marinus Pharmaceuticals, Inc.. A bullish signal can be intrerpreted if you notice a large amount of contracts traded for strikes that are considered out of the money and expiring in the near future. You can then compare the overall volume for that strike to the open interest at the beginning of the day. A larger volume of option contracts traded compared to the open interest would mean this is a new position that is being opened.


Trade History